by Nicole Overmars | May 3, 2022 | Press Releases
Aalborg – We are pleased to announce that Preben Bruun Nyzell has been invited to the Anglonordic Life Science Conference that takes place in London on May 4-5. About Anglonordic The Anglonordic Life Science Conference is an investment and partnering...
by Nicole Overmars | Apr 12, 2022 | Press Releases
Aalborg – US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. 2N Pharma is thrilled to announce that the US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. We are extremely grateful for the financial support that will...
by Nicole Overmars | Apr 5, 2022 | Press Releases
Boston – We are thrilled to announce that Preben Bruun-Nyzell and John Nieland will attend DKBIO 2022 in Boston on April 6-7. About DKBIO Innovation Centre Denmark and the Danish Ministry of Foreign Affairs are hosting DKBIO 2022. One of our investors,...
by Nicole Overmars | Mar 24, 2022 | Press Releases
2N Pharma has big ambitions. Our mission is to do what no one has yet managed: develop effective drugs with our innovative approach for the neurological diseases ALS and Parkinson’s. Unmet medical need Parkinson’s disease was first described...
by Nicole Overmars | Feb 11, 2022 | Press Releases
On the occasion of today’s International Day of Women and Girls in Science, we spoke with Angelique Corthals, an inspiring woman in STEM. She is a multifaceted scientist, and has years of experience in the fields of metabolic dysfunction and neurological...
by Nicole Overmars | Jan 19, 2022 | Press Releases
AALBORG, Denmark – We are thrilled to announce that 2N Pharma will be a showcase presenter at BioSeed 2022. 2N Pharma will attend BioSeed, OBN’s Early-Stage Life Science Investment Event. The event takes place in London on January 25. Chair Alex Leech, CEO Preben...
Recent Comments